Efficacy and safety of ticagrelor monotherapy following a brief DAPT vs. prolonged 12-month DAPT in ACS patients post-PCI: a meta-analysis of RCTs.

Background: As per current guidelines, acute coronary syndrome (ACS) patients who undergo percutaneous coronary intervention (PCI) should be started on dual antiplatelet therapy (DAPT) for a period of 12 months. Objective: To assess the efficacy and safety of brief DAPT (up to 3 months) succeeded by...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Clinical Pharmacology Vol. 80; no. 12; pp. 1871 - 1883
Autores principales:	Qamar, Usama, Naeem, Farhan, Maqsood, Muhammad Talha, Khan, Maleeka Zamurad, Imtiaz, Zeeshan, Saeed, Fatima, Gupta, Neelesh, Brohi, Fnu Zafarullah, Mkpozi, Celestine, Sattar, Yasar
Formato:	meta analysis research systematic review tables/charts Journal Article
Publicado:	Springer Nature Dec2024
Acceso en línea:	Ver este registro en EBSCOhost